People who receive<unk>  should avoid the concurrent administration of a live vaccine due to the treatment's potential to inhibit replication of a live vaccine virus indicated for prevention of Ebola virus infection and possibly reduce the vaccine's efficacy.
Atoltivimab/maftivimab/odesivimab
Casirivimab/imdevimab
Bamlanivimab/etesevimab
Tixagevimab/cilgavimab
Valoctocogene roxaparvovec
Baloxavir marboxil
Darunavir/cobicistat
Belantamab mafodotin